Skip to main content
. 2012 May 31;55(5):e35–e44. doi: 10.1093/cid/cis513

Table 1.

Patient Characteristics

Characteristic PCV7 (N = 91) PPSV23 (N = 90) P value
Age, years 63 ± 9 64 ± 10 .56
Male, n, (%) 59 (65) 52 (58) .36
Caucasian, (%) 70 (77) 71 (79) .86
FEV1, (L) 1.33 ± 0.53 1.27 ± 0.50 .37
FEV1, (% predicted) 44.9 ± 15 44.8 ± 15 .96
FVC 2.91 ± 0.85 2.86 ± 1.0 .73
FEV1/FVC 0.46 ± 0.13 0.45 ± 0.12 .66
Oxygen use, n (%) 21 (23) 29 (32) .19
Inhaled corticosteroid use, n (%) 60 (66) 58 (64) .88
Pack-Years smoking 52 ± 28 55 ± 27 .48
Current Smoker, n (%) 33 (36) 32 (36) 1.0
Co-Morbid Illness, n (%)
Coronary Artery Disease 22 (24) 19 (21) .72
Congestive Heart Failure 3 (3) 5 (6) .50
Stroke 3 (3) 7 (8) .21
Diabetes Mellitus 8 (9) 7 (8) 1.0
Prior Malignancy 9 (10) 12 (13) .50
Anemia 12 (13) 5 (6) .12
Previous Pneumonia, n (%) 44 (48) 45 (50) .88
Exacerbation History (Year Prior to Enrollment)
Hospitalized or unscheduled emergency visit, n (%) 18 (20) 11 (12) .22
Number of hospitalizations or unscheduled ED visits in past year for those with any. 1.2 ± 0.9 1.2 ± 0.6 .90
Received systemic steroids and/or antibiotics, n (%) 38 (42) 34 (38) .65
Number of courses of systemic steroids and/or antibiotics in past year for those with any courses. 1.9 ± 1.6 1.6 ± 1.0 .28
Vaccine naive, n (%) 45 (49) 42 (47) .77
Years since last vaccination 7.6 ± 2.7 8.4 ± 3.5 .19

Results are mean ± standard deviation, unless indicated.

Abbreviations: ED, emergency department; FEV1, forced expiratory volume; FVC, forced vital capacity; L, liters; PCV7, 7-valent diphtheria-conjugated pneumococcal polysaccharide vaccine; PPSV23, 23-valent pneumococcal polysaccharide vaccine.